Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21037/jtd.2016.03.14 http://scihub22266oqcxt.onion/10.21037/jtd.2016.03.14 C4990666!4990666!27606082     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Thorac+Dis 2016 ; 8 (Suppl 6): S517-27 Nephropedia Template TP {{tp|p=27606082|t=2016. Stereotactic body radiotherapy: current strategies and future development |pdf=|usr=}}{{27606082}} gab.com Text Stereotactic body radiotherapy: current strategies and future development JO: J Thorac Dis http://www.kidney.de/pget.php?&tw=1&pmid=27606082 #FOAvip Stereotactic body radiotherapy (SBRT) has emerged as the standard treatment for medically inoperable early-staged non-small cell lung cancer (NSCLC). The local control rate after SBRT is over 90%. Some forms of tumour motion management and image-guided radiation delivery techniques are the prerequisites for fulfilment of its goal to deliver a high radiation dose to the tumour target without overdosing surrounding normal tissues. In this review, the current strategies of tumour motion management will be discussed, followed by an overview of various image-guided radiotherapy (RT) systems and devices available for clinical practice. Besides medically inoperable stage I NSCLC, SBRT has also been widely adopted for treatment of oligometastasis involving the lungs. Its possible applications in various other cancer illnesses are under extensive exploration. The progress of SBRT is critically technology-dependent. With advancement of technology, the ideal of personalised, effective and yet safe SBRT is already on the horizon. Twit Text FOAVip Stereotactic body radiotherapy: current strategies and future development ????J Thorac Dis http://www.kidney.de/pget.php?&tw=1&pmid=27606082 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27606082 #FOAvip English Wikipedia <ref>{{Cite pmid|27606082}}</ref> Stereotactic body radiotherapy: current strategies and future development #MMPMID27606082 Tsang MWK J Thorac Dis 2016[Jul]; 8 (Suppl 6): S517-27 PMID27606082show ga Stereotactic body radiotherapy (SBRT) has emerged as the standard treatment for medically inoperable early-staged non-small cell lung cancer (NSCLC). The local control rate after SBRT is over 90%. Some forms of tumour motion management and image-guided radiation delivery techniques are the prerequisites for fulfilment of its goal to deliver a high radiation dose to the tumour target without overdosing surrounding normal tissues. In this review, the current strategies of tumour motion management will be discussed, followed by an overview of various image-guided radiotherapy (RT) systems and devices available for clinical practice. Besides medically inoperable stage I NSCLC, SBRT has also been widely adopted for treatment of oligometastasis involving the lungs. Its possible applications in various other cancer illnesses are under extensive exploration. The progress of SBRT is critically technology-dependent. With advancement of technology, the ideal of personalised, effective and yet safe SBRT is already on the horizon. äStereotactic body radiotherapy: current strategies and future developm(epmc).pdf DeepDyve Pubget Overpricing